Lear Corporation (NYSE:LEA – Get Free Report) announced a quarterly dividend on Thursday, May 14th. Stockholders of record on Wednesday, June 3rd will be given a dividend of 0.77 per share by the auto parts company on Tuesday, June 23rd. This represents a c) dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Wednesday, June 3rd.
Lear has increased its dividend payment by an average of 0.2%annually over the last three years. Lear has a payout ratio of 22.8% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Lear to earn $16.90 per share next year, which means the company should continue to be able to cover its $3.08 annual dividend with an expected future payout ratio of 18.2%.
Lear Price Performance
LEA opened at $139.09 on Friday. The stock has a fifty day moving average of $123.77 and a 200-day moving average of $120.06. The firm has a market capitalization of $6.97 billion, a P/E ratio of 13.91, a PEG ratio of 0.70 and a beta of 1.21. Lear has a 12-month low of $86.14 and a 12-month high of $142.84. The company has a quick ratio of 1.05, a current ratio of 1.33 and a debt-to-equity ratio of 0.51.
About Lear
Lear Corporation (NYSE: LEA) is a global supplier of automotive seating and electrical distribution systems. The company designs, engineers and manufactures complete seat systems, seat components and power solutions for major vehicle manufacturers. Its electrical business delivers modules and components for battery management, infotainment, body and safety electronics, as well as advanced connectivity and electrification solutions.
The seating division develops lightweight, ergonomic seat structures, trim and mechanisms that address comfort, safety and environmental targets.
Recommended Stories
- Five stocks we like better than Lear
- Karman: Defense Darling’s Outlook Strengthens After 40% Drop
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
Receive News & Ratings for Lear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lear and related companies with MarketBeat.com's FREE daily email newsletter.
